Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
In 1999, 80% of French neonatal centres used corticosteroids, mainly betamethasone, to prevent or to treat bronchopulmonary dysplasia (BPD).1 As many data suggested a low benefit/risk ratio, an updated assessment of this use was necessary.2–5
Questionnaires addressing the use of and indications for corticosteroids were sent to all French neonatal centres.
The study was performed over five months (July–November 2006). Questionnaires were sent to 202 centres, of which 186 (92%) centres completed them. Of these 186 centres, 147 (79%) units had a standard protocol for corticosteroids use, …
Funding: This study was funded by the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS).
Competing interests: None.